Tag: Becton, Dickinson & Co. (BD)

FRANKLIN LAKES, N.J., and MURRAY HILL, N.J. - Becton, Dickinson and Company will buy C. R. Bard for $24 billion, the companies announced April 23. The deal builds on BD's position in medication management and infection prevention, and increases its opportunities in fast-growing clinical areas like vascular therapy, according to a press release. "Combining with Bard will accelerate our ability to offer more comprehensive, clinically relevant solutions to customers and patients around the...